# A Study Evaluating the Efficacy and Safety of Sildenafil in Men With Traumatic Spinal Cord Injury and Erectile Dysfunction

> **NCT00654082** · PHASE4 · COMPLETED · sponsor: **Pfizer's Upjohn has merged with Mylan to form Viatris Inc.** · enrollment: 88 (actual)

## Conditions studied

- Spinal Cord Injury
- Erectile Dysfunction
- Spinal Cord Trauma
- Injuries, Spinal Cord
- Impotence

## Interventions

- **DRUG:** sildenafil
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00654082
- **Lead sponsor:** Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-09
- **Primary completion:** —
- **Final completion:** 2003-08
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2021-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00654082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00654082, "A Study Evaluating the Efficacy and Safety of Sildenafil in Men With Traumatic Spinal Cord Injury and Erectile Dysfunction". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00654082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*